References
1. Lazcano –Ponce EC, Miquel JF, Munoz N et al. Epidemiology and molecular pathology of gall bladder cancer. Cancer J Clin 2001;51(6):349-364.
2. Vitetta L, Sali A, Little P, Mrazek L. Gall stones and gall bladder carcinoma. Aust N z J Surg 2000;70(9):667-73.
3. Nagahashi M, Ajioka Y, Lang I, Szeintirmay Z. et al. Genetic changes of P53 , K-ras and microsatellite instability in gall bladder carcinoma in high incidence areas of japan and Hungary. World J Gastroenterol 2008;14:70-5.
4. Lai CH, Lau WY. Gall bladder cancer- a comprehensive review. Surgeon 2008;6(2):101-10.
5. Ghosh Y, Thakurdas B. Carcinoma gall bladder : A review of literature . Int J Scien Study 2015;2:98-103.
6. GerdesJ , Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer.1983;31:13-20.
7. Gerdes J, Lemke H, Baisch H, Walker H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67 . J Immunol. 1984;41:229-237.
8. Cattoretti G, Becker MH, Key G et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen ( MIB1 and MIB3 ) detect proliferating cells in microwave –processed formalin-fixed, paraffine sections. J Pathol.1992;168:357-363.
9. Yerushalmi R, Woods R, Ravdin PM. et al. Ki-67 in breast cancer : prognostic and predictive potential. Lancet Oncol.2010; 11:174-180.
10. Scholzen T, Gerdes J. “ The Ki-67 protein : from the known and the unknown”. J Cell Physiol.2000 ;182(3):311-322.
11. Bisgaard LM. Young age colorectal cancer and identification of hereditary non-polyposis colorectal cancer chorts. Br J Surg.2007;94:1055-6.
12. Bosari S, Monechini L, Graziani D. et al. Bcl-2 oncoprotein in colorectal heperp-lastic polyps, adenoms and adenocar-cinomas. Hum Pathol.1995;26(5):534-540.
13. Franklin WA, Bibbo M, Doria MI, et al. Quantitation of estrogenrecptor content and Ki-67 staining in breast carcinoma by the micro TICAS image analysis system. Anal quant cytolHistol. 1987;9:279-283.
14. Kim NK, Park JK, Leek X. P53, Bcl-2 and Ki-67 expression according to tumour response after concurrent chemoradioth-erapy for advanced rectal cancer. Ann Surg. Oncol.2001;8(5):418-422.
15. Velera V, Yokoyama N, Walter B, Okamoto H. et al. Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma. Br J Surg.2005;92:1002-7.
16. Ustymowicz KG, Pryczynicz A, Kemona A et al. Correlation between proliferation markers : PCNA, Ki-67 MCM-2 and anti apoptotic protein bcl2 in colorectal cancer. Anticancer Research 2009;29(8):3049-3052.
17. Wang X , Zhang J, Chen J. Result of p53, ki67 protein expression in cholangioc-arcinoma with in situ hybridization and immunohistochemistry methods. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 ; 22(1):57-60.
18. Spyratos F , FerreroPous M, Trassard M, Hacene K, Phillips E, Tubiana-Hulin M, Le Doussal V. Correlation between MIB1and other proliferation markers: clinical implications of the MIB1 cutoff value. Cancer. 2002 15;94(8):215-19.
19. Lee CS. Differences in cell proliferation and prognostic significance of proliferatingcell nuclear antigen and Ki67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Cancer. 1996 ;78(9):1881-7.
20. Hidalgo Grau LA , Badia JM, Salvador CA, Monsó TS, Canaleta JF, Nogues JM, Sala JS. Gall bladder carcinoma: The role of P53 protein overexpression and Ki67 antigen expression as prognostic markers. HPB (Oxford). 2004;6(3):174-80
21. Doval DC , Azam S , Sinha R , Batra U , Mehta A. Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxy-genase2, cyclin D1, human epidermal receptor2 and Ki67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma. J Carcinog. 2014;13:10.
22. Xuan YH , Choi YL, Shin YK, Kook MC, Chae SW, Park SM, Chae HB, Kim SH. An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions. Histol Histopathol. 2005; 20(1):59-66.
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.50
